Table of Contents 1 Oxcarbazepine Market Overview 1.1 Product Overview and Scope of Oxcarbazepine 1.2 Oxcarbazepine Segment by Type 1.2.1 Global Oxcarbazepine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Tablets (150mg, 300mg, 600mg) 1.2.3 Oral Suspension 1.3 Oxcarbazepine Segment by Application 1.3.1 Oxcarbazepine Sales Comparison by Application: 2020 VS 2026 1.3.2 Pediatric Use (Aged 2-4 years, 4-16 years) 1.3.3 Adult Use 1.4 Global Oxcarbazepine Market Size Estimates and Forecasts 1.4.1 Global Oxcarbazepine Revenue 2015-2026 1.4.2 Global Oxcarbazepine Sales 2015-2026 1.4.3 Oxcarbazepine Market Size by Region: 2020 Versus 2026 2 Global Oxcarbazepine Market Competition by Manufacturers 2.1 Global Oxcarbazepine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Oxcarbazepine Revenue Share by Manufacturers (2015-2020) 2.3 Global Oxcarbazepine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Oxcarbazepine Manufacturing Sites, Area Served, Product Type 2.5 Oxcarbazepine Market Competitive Situation and Trends 2.5.1 Oxcarbazepine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Oxcarbazepine Players (Opinion Leaders) 3 Oxcarbazepine Retrospective Market Scenario by Region 3.1 Global Oxcarbazepine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Oxcarbazepine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Oxcarbazepine Market Facts & Figures by Country 3.3.1 North America Oxcarbazepine Sales by Country 3.3.2 North America Oxcarbazepine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Oxcarbazepine Market Facts & Figures by Country 3.4.1 Europe Oxcarbazepine Sales by Country 3.4.2 Europe Oxcarbazepine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Oxcarbazepine Market Facts & Figures by Region 3.5.1 Asia Pacific Oxcarbazepine Sales by Region 3.5.2 Asia Pacific Oxcarbazepine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Oxcarbazepine Market Facts & Figures by Country 3.6.1 Latin America Oxcarbazepine Sales by Country 3.6.2 Latin America Oxcarbazepine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Oxcarbazepine Market Facts & Figures by Country 3.7.1 Middle East and Africa Oxcarbazepine Sales by Country 3.7.2 Middle East and Africa Oxcarbazepine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Oxcarbazepine Historic Market Analysis by Type 4.1 Global Oxcarbazepine Sales Market Share by Type (2015-2020) 4.2 Global Oxcarbazepine Revenue Market Share by Type (2015-2020) 4.3 Global Oxcarbazepine Price Market Share by Type (2015-2020) 4.4 Global Oxcarbazepine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Oxcarbazepine Historic Market Analysis by Application 5.1 Global Oxcarbazepine Sales Market Share by Application (2015-2020) 5.2 Global Oxcarbazepine Revenue Market Share by Application (2015-2020) 5.3 Global Oxcarbazepine Price by Application (2015-2020) 6 Company Profiles and Key Figures in Oxcarbazepine Business 6.1 Novartis (Trileptal) 6.1.1 Corporation Information 6.1.2 Novartis (Trileptal) Description, Business Overview and Total Revenue 6.1.3 Novartis (Trileptal) Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Novartis (Trileptal) Products Offered 6.1.5 Novartis (Trileptal) Recent Development 6.2 Supernus Pharmaceuticals (Oxtellar XR) 6.2.1 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Production Sites and Area Served 6.2.2 Supernus Pharmaceuticals (Oxtellar XR) Description, Business Overview and Total Revenue 6.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Supernus Pharmaceuticals (Oxtellar XR) Products Offered 6.2.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Development 6.3 Sun Pharm 6.3.1 Sun Pharm Oxcarbazepine Production Sites and Area Served 6.3.2 Sun Pharm Description, Business Overview and Total Revenue 6.3.3 Sun Pharm Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Sun Pharm Products Offered 6.3.5 Sun Pharm Recent Development 6.4 Ranbaxy Pharmaceuticals 6.4.1 Ranbaxy Pharmaceuticals Oxcarbazepine Production Sites and Area Served 6.4.2 Ranbaxy Pharmaceuticals Description, Business Overview and Total Revenue 6.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Ranbaxy Pharmaceuticals Products Offered 6.4.5 Ranbaxy Pharmaceuticals Recent Development 6.5 Jubilant Generics 6.5.1 Jubilant Generics Oxcarbazepine Production Sites and Area Served 6.5.2 Jubilant Generics Description, Business Overview and Total Revenue 6.5.3 Jubilant Generics Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Jubilant Generics Products Offered 6.5.5 Jubilant Generics Recent Development 6.6 Taro Pharmaceuticals 6.6.1 Taro Pharmaceuticals Oxcarbazepine Production Sites and Area Served 6.6.2 Taro Pharmaceuticals Description, Business Overview and Total Revenue 6.6.3 Taro Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Taro Pharmaceuticals Products Offered 6.6.5 Taro Pharmaceuticals Recent Development 6.7 Mylan 6.6.1 Mylan Oxcarbazepine Production Sites and Area Served 6.6.2 Mylan Description, Business Overview and Total Revenue 6.6.3 Mylan Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Mylan Products Offered 6.7.5 Mylan Recent Development 6.8 Stada Group 6.8.1 Stada Group Oxcarbazepine Production Sites and Area Served 6.8.2 Stada Group Description, Business Overview and Total Revenue 6.8.3 Stada Group Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Stada Group Products Offered 6.8.5 Stada Group Recent Development 6.9 Glenmark Pharmaceuticals 6.9.1 Glenmark Pharmaceuticals Oxcarbazepine Production Sites and Area Served 6.9.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue 6.9.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Glenmark Pharmaceuticals Products Offered 6.9.5 Glenmark Pharmaceuticals Recent Development 6.10 ANI Pharmaceuticals 6.10.1 ANI Pharmaceuticals Oxcarbazepine Production Sites and Area Served 6.10.2 ANI Pharmaceuticals Description, Business Overview and Total Revenue 6.10.3 ANI Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.10.4 ANI Pharmaceuticals Products Offered 6.10.5 ANI Pharmaceuticals Recent Development 6.11 Teva Pharmaceutical 6.11.1 Teva Pharmaceutical Oxcarbazepine Production Sites and Area Served 6.11.2 Teva Pharmaceutical Oxcarbazepine Description, Business Overview and Total Revenue 6.11.3 Teva Pharmaceutical Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Teva Pharmaceutical Products Offered 6.11.5 Teva Pharmaceutical Recent Development 6.12 Roxane Laboratories 6.12.1 Roxane Laboratories Oxcarbazepine Production Sites and Area Served 6.12.2 Roxane Laboratories Oxcarbazepine Description, Business Overview and Total Revenue 6.12.3 Roxane Laboratories Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Roxane Laboratories Products Offered 6.12.5 Roxane Laboratories Recent Development 6.13 Nobelpharma 6.13.1 Nobelpharma Oxcarbazepine Production Sites and Area Served 6.13.2 Nobelpharma Oxcarbazepine Description, Business Overview and Total Revenue 6.13.3 Nobelpharma Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Nobelpharma Products Offered 6.13.5 Nobelpharma Recent Development 6.14 Apotex 6.14.1 Apotex Oxcarbazepine Production Sites and Area Served 6.14.2 Apotex Oxcarbazepine Description, Business Overview and Total Revenue 6.14.3 Apotex Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Apotex Products Offered 6.14.5 Apotex Recent Development 6.15 Nexgen pharma 6.15.1 Nexgen pharma Oxcarbazepine Production Sites and Area Served 6.15.2 Nexgen pharma Oxcarbazepine Description, Business Overview and Total Revenue 6.15.3 Nexgen pharma Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Nexgen pharma Products Offered 6.15.5 Nexgen pharma Recent Development 6.16 Amneal Pharmaceuticals 6.16.1 Amneal Pharmaceuticals Oxcarbazepine Production Sites and Area Served 6.16.2 Amneal Pharmaceuticals Oxcarbazepine Description, Business Overview and Total Revenue 6.16.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Amneal Pharmaceuticals Products Offered 6.16.5 Amneal Pharmaceuticals Recent Development 6.17 Hikma Pharmaceuticals 6.17.1 Hikma Pharmaceuticals Oxcarbazepine Production Sites and Area Served 6.17.2 Hikma Pharmaceuticals Oxcarbazepine Description, Business Overview and Total Revenue 6.17.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Hikma Pharmaceuticals Products Offered 6.17.5 Hikma Pharmaceuticals Recent Development 6.18 Jamp Pharma 6.18.1 Jamp Pharma Oxcarbazepine Production Sites and Area Served 6.18.2 Jamp Pharma Oxcarbazepine Description, Business Overview and Total Revenue 6.18.3 Jamp Pharma Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.18.4 Jamp Pharma Products Offered 6.18.5 Jamp Pharma Recent Development 6.19 Neuraxpharm 6.19.1 Neuraxpharm Oxcarbazepine Production Sites and Area Served 6.19.2 Neuraxpharm Oxcarbazepine Description, Business Overview and Total Revenue 6.19.3 Neuraxpharm Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.19.4 Neuraxpharm Products Offered 6.19.5 Neuraxpharm Recent Development 6.20 Orion Corporation 6.20.1 Orion Corporation Oxcarbazepine Production Sites and Area Served 6.20.2 Orion Corporation Oxcarbazepine Description, Business Overview and Total Revenue 6.20.3 Orion Corporation Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.20.4 Orion Corporation Products Offered 6.20.5 Orion Corporation Recent Development 6.21 Sihuan Pharm 6.21.1 Sihuan Pharm Oxcarbazepine Production Sites and Area Served 6.21.2 Sihuan Pharm Oxcarbazepine Description, Business Overview and Total Revenue 6.21.3 Sihuan Pharm Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.21.4 Sihuan Pharm Products Offered 6.21.5 Sihuan Pharm Recent Development 6.22 Humanwell Healthcare 6.22.1 Humanwell Healthcare Oxcarbazepine Production Sites and Area Served 6.22.2 Humanwell Healthcare Oxcarbazepine Description, Business Overview and Total Revenue 6.22.3 Humanwell Healthcare Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.22.4 Humanwell Healthcare Products Offered 6.22.5 Humanwell Healthcare Recent Development 6.23 Huikang Pharmaceutical 6.23.1 Huikang Pharmaceutical Oxcarbazepine Production Sites and Area Served 6.23.2 Huikang Pharmaceutical Oxcarbazepine Description, Business Overview and Total Revenue 6.23.3 Huikang Pharmaceutical Oxcarbazepine Sales, Revenue and Gross Margin (2015-2020) 6.23.4 Huikang Pharmaceutical Products Offered 6.23.5 Huikang Pharmaceutical Recent Development 7 Oxcarbazepine Manufacturing Cost Analysis 7.1 Oxcarbazepine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Oxcarbazepine 7.4 Oxcarbazepine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Oxcarbazepine Distributors List 8.3 Oxcarbazepine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Oxcarbazepine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Oxcarbazepine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Oxcarbazepine by Type (2021-2026) 10.2 Oxcarbazepine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Oxcarbazepine by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Oxcarbazepine by Application (2021-2026) 10.3 Oxcarbazepine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Oxcarbazepine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Oxcarbazepine by Region (2021-2026) 10.4 North America Oxcarbazepine Estimates and Projections (2021-2026) 10.5 Europe Oxcarbazepine Estimates and Projections (2021-2026) 10.6 Asia Pacific Oxcarbazepine Estimates and Projections (2021-2026) 10.7 Latin America Oxcarbazepine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Oxcarbazepine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Oxcarbazepine Sales (M Unit) Growth Rate Comparison by Type (2015-2026) Table 2. Global Oxcarbazepine Sales (M Unit) Comparison by Application: 2020 VS 2026 Table 3. Global Oxcarbazepine Market Size by Type (M Unit) (US$ Million) (2020 VS 2026) Table 4. Global Key Oxcarbazepine Manufacturers Covered in This Study Table 5. Global Oxcarbazepine Sales (M Unit) by Manufacturers (2015-2020) Table 6. Global Oxcarbazepine Sales Share by Manufacturers (2015-2020) Table 7. Global Oxcarbazepine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Oxcarbazepine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Oxcarbazepine Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Oxcarbazepine Sales Sites and Area Served Table 11. Manufacturers Oxcarbazepine Product Types Table 12. Global Oxcarbazepine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Oxcarbazepine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxcarbazepine as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Oxcarbazepine Players Table 16. Global Oxcarbazepine Sales (M Unit) by Region (2015-2020) Table 17. Global Oxcarbazepine Sales Market Share by Region (2015-2020) Table 18. Global Oxcarbazepine Revenue (Million US$) by Region (2015-2020) Table 19. Global Oxcarbazepine Revenue Market Share by Region (2015-2020) Table 20. North America Oxcarbazepine Sales by Country (2015-2020) (M Unit) Table 21. North America Oxcarbazepine Sales Market Share by Country (2015-2020) Table 22. North America Oxcarbazepine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Oxcarbazepine Revenue Market Share by Country (2015-2020) Table 24. Europe Oxcarbazepine Sales by Country (2015-2020) (M Unit) Table 25. Europe Oxcarbazepine Sales Market Share by Country (2015-2020) Table 26. Europe Oxcarbazepine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Oxcarbazepine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Oxcarbazepine Sales by Region (2015-2020) (M Unit) Table 29. Asia Pacific Oxcarbazepine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Oxcarbazepine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Oxcarbazepine Revenue Market Share by Region (2015-2020) Table 32. Latin America Oxcarbazepine Sales by Country (2015-2020) (M Unit) Table 33. Latin America Oxcarbazepine Sales Market Share by Country (2015-2020) Table 34. Latin America Oxcarbazepine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Oxcarbazepine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Oxcarbazepine Sales by Country (2015-2020) (M Unit) Table 37. Middle East and Africa Oxcarbazepine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Oxcarbazepine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Oxcarbazepine Revenue Market Share by Country (2015-2020) Table 40. Global Oxcarbazepine Sales (M Unit) by Type (2015-2020) Table 41. Global Oxcarbazepine Sales Share by Type (2015-2020) Table 42. Global Oxcarbazepine Revenue (Million US$) by Type (2015-2020) Table 43. Global Oxcarbazepine Revenue Share by Type (2015-2020) Table 44. Global Oxcarbazepine Price (USD/Unit) by Type (2015-2020) Table 45. Global Oxcarbazepine Sales (M Unit) by Application (2015-2020) Table 46. Global Oxcarbazepine Sales Market Share by Application (2015-2020) Table 47. Global Oxcarbazepine Sales Growth Rate by Application (2015-2020) Table 48. Novartis (Trileptal) Oxcarbazepine Corporation Information Table 49. Novartis (Trileptal) Description and Business Overview Table 50. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Novartis (Trileptal) Main Product Table 52. Novartis (Trileptal) Recent Development Table 53. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Corporation Information Table 54. Supernus Pharmaceuticals (Oxtellar XR) Corporation Information Table 55. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Supernus Pharmaceuticals (Oxtellar XR) Main Product Table 57. Supernus Pharmaceuticals (Oxtellar XR) Recent Development Table 58. Sun Pharm Oxcarbazepine Corporation Information Table 59. Sun Pharm Corporation Information Table 60. Sun Pharm Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Sun Pharm Main Product Table 62. Sun Pharm Recent Development Table 63. Ranbaxy Pharmaceuticals Oxcarbazepine Corporation Information Table 64. Ranbaxy Pharmaceuticals Corporation Information Table 65. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Ranbaxy Pharmaceuticals Main Product Table 67. Ranbaxy Pharmaceuticals Recent Development Table 68. Jubilant Generics Oxcarbazepine Corporation Information Table 69. Jubilant Generics Corporation Information Table 70. Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Jubilant Generics Main Product Table 72. Jubilant Generics Recent Development Table 73. Taro Pharmaceuticals Oxcarbazepine Corporation Information Table 74. Taro Pharmaceuticals Corporation Information Table 75. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Taro Pharmaceuticals Main Product Table 77. Taro Pharmaceuticals Recent Development Table 78. Mylan Oxcarbazepine Corporation Information Table 79. Mylan Corporation Information Table 80. Mylan Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Mylan Main Product Table 82. Mylan Recent Development Table 83. Stada Group Oxcarbazepine Corporation Information Table 84. Stada Group Corporation Information Table 85. Stada Group Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. Stada Group Main Product Table 87. Stada Group Recent Development Table 88. Glenmark Pharmaceuticals Oxcarbazepine Corporation Information Table 89. Glenmark Pharmaceuticals Corporation Information Table 90. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Glenmark Pharmaceuticals Main Product Table 92. Glenmark Pharmaceuticals Recent Development Table 93. ANI Pharmaceuticals Oxcarbazepine Corporation Information Table 94. ANI Pharmaceuticals Corporation Information Table 95. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. ANI Pharmaceuticals Main Product Table 97. ANI Pharmaceuticals Recent Development Table 98. Teva Pharmaceutical Oxcarbazepine Corporation Information Table 99. Teva Pharmaceutical Corporation Information Table 100. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. Teva Pharmaceutical Main Product Table 102. Teva Pharmaceutical Recent Development Table 103. Roxane Laboratories Oxcarbazepine Corporation Information Table 104. Roxane Laboratories Corporation Information Table 105. Roxane Laboratories Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Roxane Laboratories Main Product Table 107. Roxane Laboratories Recent Development Table 108. Nobelpharma Oxcarbazepine Corporation Information Table 109. Nobelpharma Corporation Information Table 110. Nobelpharma Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Nobelpharma Main Product Table 112. Nobelpharma Recent Development Table 113. Apotex Oxcarbazepine Corporation Information Table 114. Apotex Corporation Information Table 115. Apotex Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. Apotex Main Product Table 117. Apotex Recent Development Table 118. Nexgen pharma Oxcarbazepine Corporation Information Table 119. Nexgen pharma Corporation Information Table 120. Nexgen pharma Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. Nexgen pharma Main Product Table 122. Nexgen pharma Recent Development Table 123. Amneal Pharmaceuticals Oxcarbazepine Corporation Information Table 124. Amneal Pharmaceuticals Corporation Information Table 125. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. Amneal Pharmaceuticals Main Product Table 127. Amneal Pharmaceuticals Recent Development Table 128. Hikma Pharmaceuticals Oxcarbazepine Corporation Information Table 129. Hikma Pharmaceuticals Corporation Information Table 130. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. Hikma Pharmaceuticals Main Product Table 132. Hikma Pharmaceuticals Recent Development Table 133. Jamp Pharma Oxcarbazepine Corporation Information Table 134. Jamp Pharma Corporation Information Table 135. Jamp Pharma Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 136. Jamp Pharma Main Product Table 137. Jamp Pharma Recent Development Table 138. Neuraxpharm Oxcarbazepine Corporation Information Table 139. Neuraxpharm Corporation Information Table 140. Neuraxpharm Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 141. Neuraxpharm Main Product Table 142. Neuraxpharm Recent Development Table 143. Orion Corporation Oxcarbazepine Corporation Information Table 144. Orion Corporation Corporation Information Table 145. Orion Corporation Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 146. Orion Corporation Main Product Table 147. Orion Corporation Recent Development Table 148. Sihuan Pharm Oxcarbazepine Corporation Information Table 149. Sihuan Pharm Corporation Information Table 150. Sihuan Pharm Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 151. Sihuan Pharm Main Product Table 152. Sihuan Pharm Recent Development Table 153. Humanwell Healthcare Oxcarbazepine Corporation Information Table 154. Humanwell Healthcare Corporation Information Table 155. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 156. Humanwell Healthcare Main Product Table 157. Humanwell Healthcare Recent Development Table 158. Huikang Pharmaceutical Oxcarbazepine Corporation Information Table 159. Huikang Pharmaceutical Corporation Information Table 160. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 161. Huikang Pharmaceutical Main Product Table 162. Huikang Pharmaceutical Recent Development Table 163. Sales Base and Market Concentration Rate of Raw Material Table 164. Key Suppliers of Raw Materials Table 165. Oxcarbazepine Distributors List Table 166. Oxcarbazepine Customers List Table 167. Market Key Trends Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 169. Key Challenges Table 170. Global Oxcarbazepine Sales (M Unit) Forecast by Type (2021-2026) Table 171. Global Oxcarbazepine Sales Market Share Forecast by Type (2021-2026) Table 172. Global Oxcarbazepine Revenue (Million US$) Forecast by Type (2021-2026) Table 173. Global Oxcarbazepine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 174. Global Oxcarbazepine Sales (M Unit) Forecast by Application (2021-2026) Table 175. Global Oxcarbazepine Revenue (Million US$) Forecast by Application (2021-2026) Table 176. Global Oxcarbazepine Sales (M Unit) Forecast by Region (2021-2026) Table 177. Global Oxcarbazepine Sales Market Share Forecast by Region (2021-2026) Table 178. Global Oxcarbazepine Revenue Forecast by Region (2021-2026) (US$ Million) Table 179. Global Oxcarbazepine Revenue Market Share Forecast by Region (2021-2026) Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Oxcarbazepine Figure 2. Global Oxcarbazepine Sales Market Share by Type: 2020 VS 2026 Figure 3. Tablets (150mg, 300mg, 600mg) Product Picture Figure 4. Oral Suspension Product Picture Figure 5. Global Oxcarbazepine Consumption Market Share by Application: 2020 VS 2026 Figure 6. Pediatric Use (Aged 2-4 years, 4-16 years) Figure 7. Adult Use Figure 8. Global Oxcarbazepine Market Size 2015-2026 (US$ Million) Figure 9. Global Oxcarbazepine Sales Capacity (M Unit) (2015-2026) Figure 10. Global Oxcarbazepine Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Oxcarbazepine Sales Share by Manufacturers in 2020 Figure 12. Global Oxcarbazepine Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Oxcarbazepine Revenue in 2019 Figure 14. Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Oxcarbazepine Sales Market Share by Region (2015-2020) Figure 16. Global Oxcarbazepine Sales Market Share by Region in 2019 Figure 17. Global Oxcarbazepine Revenue Market Share by Region (2015-2020) Figure 18. Global Oxcarbazepine Revenue Market Share by Region in 2019 Figure 19. North America Oxcarbazepine Sales Market Share by Country in 2019 Figure 20. North America Oxcarbazepine Revenue Market Share by Country in 2019 Figure 21. U.S. Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 22. U.S. Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 24. Canada Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Oxcarbazepine Sales Market Share by Country in 2019 Figure 26. Europe Oxcarbazepine Revenue Market Share by Country in 2019 Figure 27. Germany Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 28. Germany Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 30. France Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 32. U.K. Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 34. Italy Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 36. Russia Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Oxcarbazepine Sales Market Share by Region in 2019 Figure 38. Asia Pacific Oxcarbazepine Revenue Market Share by Region in 2019 Figure 39. China Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 40. China Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 42. Japan Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 44. South Korea Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 46. India Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 48. Australia Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 50. Taiwan Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 52. Indonesia Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 54. Thailand Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 56. Malaysia Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 58. Philippines Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 60. Vietnam Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Oxcarbazepine Sales Market Share by Country in 2019 Figure 62. Latin America Oxcarbazepine Revenue Market Share by Country in 2019 Figure 63. Mexico Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 64. Mexico Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 66. Brazil Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 68. Argentina Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Oxcarbazepine Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Oxcarbazepine Revenue Market Share by Country in 2019 Figure 71. Turkey Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 72. Turkey Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 74. Saudi Arabia Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Oxcarbazepine Sales Growth Rate (2015-2020) (M Unit) Figure 76. U.A.E Oxcarbazepine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Oxcarbazepine by Type (2015-2020) Figure 78. Sales Market Share of Oxcarbazepine by Type in 2019 Figure 79. Revenue Share of Oxcarbazepine by Type (2015-2020) Figure 80. Revenue Market Share of Oxcarbazepine by Type in 2019 Figure 81. Global Oxcarbazepine Sales Growth by Type (2015-2020) (M Unit) Figure 82. Global Oxcarbazepine Sales Market Share by Application (2015-2020) Figure 83. Global Oxcarbazepine Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Oxcarbazepine by Application (2015-2020) Figure 85. Global Revenue Share of Oxcarbazepine by Application in 2020 Figure 86. Novartis (Trileptal) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Supernus Pharmaceuticals (Oxtellar XR) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Sun Pharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Ranbaxy Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Jubilant Generics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Taro Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Stada Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. ANI Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Roxane Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Nobelpharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Apotex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Nexgen pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Jamp Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Neuraxpharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Orion Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Sihuan Pharm Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Humanwell Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. Huikang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Price Trend of Key Raw Materials Figure 110. Manufacturing Cost Structure of Oxcarbazepine Figure 111. Manufacturing Process Analysis of Oxcarbazepine Figure 112. Oxcarbazepine Industrial Chain Analysis Figure 113. Channels of Distribution Figure 114. Distributors Profiles Figure 115. Porter's Five Forces Analysis Figure 116. North America Oxcarbazepine Sales (M Unit) and Growth Rate Forecast (2021-2026) Figure 117. North America Oxcarbazepine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Europe Oxcarbazepine Sales (M Unit) and Growth Rate Forecast (2021-2026) Figure 119. Europe Oxcarbazepine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Latin America Oxcarbazepine Sales (M Unit) and Growth Rate Forecast (2021-2026) Figure 121. Latin America Oxcarbazepine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Middle East and Africa Oxcarbazepine Sales (M Unit) and Growth Rate Forecast (2021-2026) Figure 123. Middle East and Africa Oxcarbazepine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Asia Pacific Oxcarbazepine Sales (M Unit) and Growth Rate Forecast (2021-2026) Figure 125. Asia Pacific Oxcarbazepine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 126. Bottom-up and Top-down Approaches for This Report Figure 127. Data Triangulation Figure 128. Key Executives Interviewed

Novartis (Trileptal) Supernus Pharmaceuticals (Oxtellar XR) Sun Pharm Ranbaxy Pharmaceuticals Jubilant Generics Taro Pharmaceuticals Mylan Stada Group Glenmark Pharmaceuticals ANI Pharmaceuticals Teva Pharmaceutical Roxane Laboratories Nobelpharma Apotex Nexgen pharma Amneal Pharmaceuticals Hikma Pharmaceuticals Jamp Pharma Neuraxpharm Orion Corporation Sihuan Pharm Humanwell Healthcare Huikang Pharmaceutical